Search Results
SABCS22: Sara Tolaney, MD, MPH | Dana-Farber Cancer Institute
SABCS22: Ann Partridge, MD, MPH | Dana-Farber Cancer Institute
Sara M. Tolaney, MD, MPH discusses the TAILORx study
Sara M. Tolaney, MD, MPH, provides an overview of the results from the SOPHIA trial
Sara M. Tolaney, MD, MPH, shares outcomes from the MONALEESA-7 trial
Dr. Tolaney on Deescalating Therapy in Stage I HER2+ Breast Cancer
Dr. Tolaney on Platinum-Based Therapy in Neoadjuvant Setting of TNBC
SABCS 2022 highlights
Improving the Experience of Living with Cancer
SABCS 2022 highlights
Maintenance w/ ET + ribociclib after 1L chemotherapy in HR+/HER2- metastatic breast cancer
Brigham Health Int'l/Dana Farber Cancer Institute—Delivering Care during the Time of Covid19"
